Verastem (VSTM) Profit After Tax Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.48% |
| Dec 31, 2025 | -10.63% |
| Sep 30, 2025 | -56.87% |
| Jun 30, 2025 | -2.42% |
| Mar 31, 2025 | -6.52% |
| Dec 31, 2024 | -10.73% |
| Sep 30, 2024 | 4.48% |
| Jun 30, 2024 | 27.84% |
| Mar 31, 2024 | 2.33% |
| Dec 31, 2023 | -19.25% |
| Sep 30, 2023 | 1.59% |
| Jun 30, 2023 | -5.74% |
| Mar 31, 2023 | 5.68% |
| Dec 31, 2022 | 1.62% |
| Sep 30, 2022 | 4.79% |
| Jun 30, 2022 | -10.32% |
| Mar 31, 2022 | -5.46% |
| Dec 31, 2021 | -7.18% |
| Sep 30, 2021 | -23.53% |
| Jun 30, 2021 | -14.55% |
| Mar 31, 2021 | -12.63% |
| Dec 31, 2020 | -10.86% |
| Sep 30, 2020 | 23.31% |
| Jun 30, 2020 | -8.39% |
| Mar 31, 2020 | -20.14% |
| Dec 31, 2019 | -22.69% |
| Sep 30, 2019 | -17.72% |
| Jun 30, 2019 | -26.51% |
| Mar 31, 2019 | -23.88% |
| Dec 31, 2018 | -0.04% |
| Sep 30, 2018 | -15.39% |
| Jun 30, 2018 | -12.37% |
| Mar 31, 2018 | -18.43% |
| Dec 31, 2017 | -18.15% |
| Sep 30, 2017 | -17.41% |
| Jun 30, 2017 | -14.51% |
| Mar 31, 2017 | -13.61% |
| Dec 31, 2016 | -14.18% |
| Sep 30, 2016 | -14.38% |
| Jun 30, 2016 | -28.09% |
| Mar 31, 2016 | -48.56% |